Luca Paoluzzi

Response to anti-PD1 therapy with nivolumab in metastatic sarcomas

Luca Paoluzzi, Adrienne Cacavio, Munir Ghesani et al. · Clinical Sarcoma Research · 2016 · 215 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma

Luca Paoluzzi, Mithat Gönen, Jeffrey R. Gardner et al. · Blood · 2008 · 147 citations · Full text

Medicine, Cancer Biology, Oncology +8

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies

Luca Paoluzzi, Mithat Gönen, Govind Bhagat et al. · Blood · 2008 · 117 citations · Full text

Medicine, Oncology, Pharmacology +14

Influence of Genetic Variants in <i>UGT1A1</i> and <i>UGT1A9</i> on the In Vivo Glucuronidation of SN‐38

Luca Paoluzzi, Arun S. Singh, Douglas K. Price et al. · The Journal of Clinical Pharmacology · 2004 · 111 citations

Medicine, Pharmacokinetics, Pharmacology +14

Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38

Arun S. Singh, Luca Paoluzzi, Douglas K. Price et al. · Journal of Clinical Oncology · 2004 · 86 citations

Life Sciences, Genetics, Pharmacology +13